MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Evoked resonant neural activity within the dorsolateral subthalamic nucleus as a biomarker for the targeting of deep brain stimulation for Parkinson’s disease

    H. Simpson, S. Xu, W. Lee, A. Begg, K. Bulluss, H. Mcdermott, W. Thevathasan, T. Perera (Melbourne, Australia)

    Objective: The objective of the study was to determine the anatomical localisation of evoked resonant neural activity (ERNA), which is being investigated as a potential…
  • 2022 International Congress

    The phenomenon of unexpectedly high functional mobility in people with typical Parkinson’s disease. A cross-sectional data analysis.

    A-M. Hanff, C. Mccrum, G. Aguayo, A. Rauschenberger, A. Leist, R. Krüger, M. Zeegers (Strassen, Luxembourg)

    Objective: To describe the frequency of people with typical Parkinson’s disease (PD) with unexpectedly high functional mobility (a high functional mobility despite the presence of…
  • 2022 International Congress

    Novel insights into the genetic basis of Indian patients with Progressive supranuclear palsy (PSP)

    S. Dey, M. Debnath, R. Yelamanchi, N. Kamble, V. Holla, P. Pal, R. Yadav (Bengaluru, India)

    Objective: To investigate the impact of four major risk genes, identified by genome-wide association studies (GWAS) in Indian patients with sporadic Progressive Supranuclear Palsy (PSP).…
  • 2022 International Congress

    Adverse drug reactions to apomorphine: a worldwide pharmacovigilancedatabase analysis

    M. Auffret, C. Le Corre, LM. Scailteux, M. Vérin, E. Polard (Rennes, France)

    Objective: To determine the safety profile of apomorphine (expected vs. new signals), regardless of the indication and route of administration. Background: Adverse drug reactions (ADR)…
  • 2022 International Congress

    Occupational Therapy for People with Parkinson’s Disease: A SWOT Analysis

    A. Cavaglion, M. Duvdevani, N. Siegelman, R. Kizony, G. Yogev-Seligmann (Haifa, Israel)

    Objective: To identify factors that lead to this low utilization of occupational therapy, while suggesting possible strategies for promoting such services. Background: Despite the important…
  • 2022 International Congress

    Low-dose lithium therapy associated with increased PBMC Nurr1 and SOD1 expression in Parkinson’s disease: a pilot study.

    T. Guttuso, JR., R. Shepherd, M. Tamano, M. Ramanathan, V. Frerichs, L. Frick (Williamsville, USA)

    Objective: To determine the effects of lithium therapy on blood-based biomarkers in Parkinson’s disease (PD). Background: Lithium has multiple neuroprotective actions and may account for…
  • 2022 International Congress

    A Study of Battery Replacement Characteristics of Patients with Parkinson’s Disease and Factors Influencing Battery Drain

    P. Sharma, P. Pal, D. Srinivas, N. Kamble, R. Yadav, V. Holla (Bangalore, India)

    Objective: To correlate the clinical and stimulation parameters in patients with PD who have undergone DBS and battery replacement Background: Battery life depends on the…
  • 2022 International Congress

    MR imaging features of Dentatorubral-pallidoluysian atrophy (DRPLA): a case report

    H. Queirós, I. Carneiro, E. Martins, A. Morgadinho, D. Pereira, G. Cordeiro (Coimbra, Portugal)

    Objective: To describe MRI signs suggestive of dentatorubral-pallidoluysian atrophy (DRPLA) that may warrant genetic testing. Background: Dentatorubral-pallidoluysian atrophy (DRPLA) is a rare autosomal dominant neurodegenerative…
  • 2022 International Congress

    A lower rate of hyposmia in non-Ashkenazi jewish patients with Parkinson’s disease: motor and non-motor disease characteristics in different ethnic groups in Israel

    ME. Cohen, E. Kohn, R. Valdman, R. Eichel, G. Yahalom (Jerusalem, Israel)

    Objective: We aim to describe clinical aspects of Parkinson's disease (PD) in different ethnic groups in Israel, focusing on Non-Ashkenzi Jews (NAJ) ethnic groups vs.…
  • 2022 International Congress

    A novel RFC1 repeat motif (ACGGG) in a patient with cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS)

    M. Thomsen, M. Borsche, F. Hinrichs, C. Helmchen, N. Brueggemann, K. Lohmann (Luebeck, Germany)

    Objective: To present a case with CANVAS with a novel repeat motif. Background: CANVAS is a late-onset neurological syndrome of combined vestibular, neuropathic, and cerebellar dysfunction. Biallelic,…
  • « Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley